|
The Indian Pharmaceutical Industry
Regulatory, Legal and Tax Overview
August 19, 2024
The pharmaceutical industry continues to flourish with numerous developments enabling the industry to grow steadily. The past year has witnessed a proactive role being played by the drug regulator in streamlining the regulatory mechanism as well as taking steps to curb practices that are likely to impact the pharma industry in the long run. In this paper, the authors dissect the regulatory framework for pharmaceutical industry, developments and potential changes to the regulatory outlook which likely to impact the industry positively.
Please click
here to access our paper.
Regards,
Tanya Kukade,
Varsha Rajesh,
Eshika Phadke
and
Dr. Milind Antani
For any help or assistance, please
email us on
[email protected].
Do visit us at
www.nishithdesai.com.
Disclaimer
The contents of this hotline should
not be construed as legal opinion. View detailed disclaimer.
This hotline does not constitute a legal
opinion and may contain information generated using
various artificial intelligence (AI) tools or assistants,
including but not limited to our in-house tool,
NaiDA. We strive to ensure the highest quality and
accuracy of our content and services. Nishith Desai
Associates is committed to the responsible use of AI
tools, maintaining client confidentiality, and adhering
to strict data protection policies to safeguard your
information.
This hotline provides general information
existing at the time of preparation. The Hotline is
intended as a news update and Nishith Desai Associates
neither assumes nor accepts any responsibility for any
loss arising to any person acting or refraining from
acting as a result of any material contained in this
Hotline. It is recommended that professional advice
be taken based on the specific facts and circumstances.
This hotline does not substitute the need to refer to
the original pronouncements.
This is not a spam email. You have received
this email because you have either requested for it or
someone must have suggested your name. Since India has
no anti-spamming law, we refer to the US directive,
which states that a email cannot be considered spam if
it contains the sender's contact information, which
this email does. In case this email doesn't concern you,
please
unsubscribe from mailing list.
 |
|
We aspire
to build the next generation
of socially-conscious lawyers
who strive to make the world
a better place.
At NDA, there
is always room for the right
people! A platform for self-driven
intrapreneurs solving complex
problems through research, academics,
thought leadership and innovation,
we are a community of non-hierarchical,
non-siloed professionals doing
extraordinary work for the world’s
best clients.
We welcome
the industry’s best talent -
inspired, competent, proactive
and research minded- with credentials
in Corporate Law (in particular
M&A/PE Fund Formation),
International Tax , TMT and
cross-border dispute resolution.
Write to
[email protected]
To learn more
about us
Click here.
|
|
Chambers
and Partners Asia
Pacific 2024:
Top Tier for Tax,
TMT, Employment,
Life Sciences, Dispute
Resolution, FinTech
Legal
Legal 500
Asia Pacific 2024:
Top Tier for Tax,
TMT, Labour &
Employment, Life
Sciences & Healthcare,
Dispute Resolution
Benchmark
Litigation Asia
Pacific 2023:
Top Tier for Tax,
Labour & Employment,
International Arbitration
AsiaLaw
Asia-Pacific 2023:
Top Tier for Tax,
TMT, Investment
Funds, Private Equity,
Labour and Employment,
Dispute Resolution,
Regulatory, Pharma
IFLR1000
2024: Top
Tier for M&A
and Private Equity
FT Innovative
Lawyers Asia Pacific
2019 Awards:
NDA ranked 2nd in
the Most Innovative
Law Firm category
(Asia-Pacific Headquartered)
RSG-Financial
Times:
India’s Most
Innovative Law Firm
2019, 2017, 2016,
2015, 2014
|
|
|
|
